Switching from one CD20-targeting therapy to another doesn't alter their ability to lower disease activity and slow disability progression.

Experts now better understand the causes of different types of chronic pain. Here's what to know about the treatments that ...

Why does the brain of some people stay sharp into their 80s and beyond? An expert explains what 25 years of exploring the ...

In a major new finding almost a decade in the making, researchers at Harvard Medical School say they’ve found a key that may ...

Susan Payrovi, MD, and Mirla Avila, MD, discuss early gut microbiome formation and its lifelong influence on MS and immune ...

The US Food and Drug Administration has approved a pill-sized device for treating rheumatoid arthritis, marking the first ...

Dogsledding taught me how to endure the cold—but cryotherapy felt like a different beast. Here’s how my body reacted to the ...

Brooke Wells is retiring at 30 after dominating the CrossFit games. She shared her top supplements for muscle-building, ...

When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...

Anthropic found that pushing AI to "evil" traits during training can help prevent bad behavior later — like giving it a ...

TUESDAY, August 5, 2025 (HealthDay News) — C. diff, which is short for Clostridioides difficile, is a type of bacteria that ...